We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Relx Plc | LSE:REL | London | Ordinary Share | GB00B2B0DG97 | ORD 14 51/116P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-11.00 | -0.33% | 3,353.00 | 3,352.00 | 3,354.00 | 3,375.00 | 3,347.00 | 3,369.00 | 589,396 | 12:16:30 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Miscellaneous Publishing | 9.16B | 1.78B | 0.9458 | 35.42 | 63.08B |
Date | Subject | Author | Discuss |
---|---|---|---|
25/8/2020 12:04 | Nice story here | netcurtains | |
23/7/2020 21:50 | Thanks pvb. Results not that bad under the circumstances, obviously the exhibitions business was gonna be awful, not quite sure why that seemed to be a shock. | spoole5 | |
23/7/2020 16:58 | 2020 Interim Results Results badly effected by COVID-19, via "Exhibitions" business, but Interim dividend maintained at 13.6p | pvb | |
23/7/2020 16:52 | I have created this new RELX (LSE:REL) thread because every time I try to look at any of the existing threads on this company it is just a confusing mess! | pvb | |
23/7/2020 16:51 | RELX - Was Reed Elsevier | pvb | |
24/3/2020 13:27 | Still buying back shares, can't be too concerned! | spoole5 | |
13/2/2020 10:43 | Backed up by a decent set of results. | patientcapital | |
24/1/2020 14:35 | New ATH I think. | patientcapital | |
21/2/2019 19:40 | Thanks both. I guess I am biased also because I dont like gearing of 200% or buybacks financed by debt, even though appears to be a Company with long history of expansion as you say. Agree your sentiments, long may it remain British controlled and independent. | electronic303 | |
21/2/2019 18:09 | There is a reason it is highly rated, it delivers steady growth year in year out. Will continue to hold | spoole5 | |
21/2/2019 17:33 | I'm afraid I take the market's present view but having held since 1990 I suppose I am slightly biased. At various times it has often looked too highly rated only to continue to impress. I bought a number of different holdings at that particular moment and Reed International is one of the very few that have remained independent. Long may it remain so. | patientcapital | |
21/2/2019 11:09 | Also I dont like Companies that buy back so many shares to prop up their share prices. Wasting £250 million which should either reduce debt (preferable) or be distributed to shareholders. | electronic303 | |
21/2/2019 11:05 | Looks too fully valued to me, for a heavily indebted Company. Margins have been declining. Maybe I am being pessimistic, but I find its business model unconvincing. One upset to the good news may see a big pullback. | electronic303 | |
21/2/2019 07:35 | Solid set of results with a positive outlook. | patientcapital | |
19/2/2019 08:08 | I saw that pugugly very interesting article indeed. | hazl | |
17/2/2019 11:53 | Could this be the Napster moment for Elsevier - Major article in theSunday Times today. The upstart is which allows free puplication and free access to research publications "Academia.edu is a platform for academics to share research papers. The company's mission is to accelerate the world's research. Academics use Academia.edu to share their research, monitor deep analytics around the impact of their research, and track the research of academics they follow. Over 74 million academics have signed up to Academia.edu, adding 22 million papers. Academia.edu attracts over 46 million unique visitors a month. Read press coverage about Academia." imo a most useful site - Still exploring - Any views would be aprcciated. | pugugly | |
10/1/2019 10:14 | Essential. I was wondering the same thing - I have some ITs with RELX shares. They like to describe themselves as "information and analytics company", in reality I think they are a publishing and exhibition company with a lot of (acquired) software for automating things like legal documentation etc. Rather too much debt in my humble opinion to be lashing out on buy backs. | shieldbug | |
08/10/2018 18:31 | Can anyone explain what it is this company actually does. Was farmilar with Reed Elsevier back in the days. Huge amount of acquisitions is what strikes me. | essentialinvestor | |
21/9/2018 11:39 | Pound's recovery against the dollar a contributory factor. | spoole5 | |
20/9/2018 21:27 | Apologies, wrong info., REL is not exD, I was thinking of Renishaw which exD today. | electronic303 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions